Transglutaminase-catalyzed crosslinking in neurological disease: from experimental evidence to therapeutic inhibition.
about
γ-Glutamylamines and neurodegenerative diseasesPolyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes.Transglutaminase in neurological disease.Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery.
P2860
Transglutaminase-catalyzed crosslinking in neurological disease: from experimental evidence to therapeutic inhibition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transglutaminase-catalyzed cro ...... nce to therapeutic inhibition.
@en
Transglutaminase-catalyzed cro ...... nce to therapeutic inhibition.
@nl
type
label
Transglutaminase-catalyzed cro ...... nce to therapeutic inhibition.
@en
Transglutaminase-catalyzed cro ...... nce to therapeutic inhibition.
@nl
prefLabel
Transglutaminase-catalyzed cro ...... nce to therapeutic inhibition.
@en
Transglutaminase-catalyzed cro ...... nce to therapeutic inhibition.
@nl
P50
P1476
Transglutaminase-catalyzed cro ...... ence to therapeutic inhibition
@en
P2093
A Vanhoutteghem
P304
P356
10.2174/187152710791012107
P577
2010-04-01T00:00:00Z